CD8+ cell depletion amplifies the acute retroviral syndrome

Journal of NeuroVirology

Volumn 10, Issue SUPPL. 1, 2004, Pages 58-66

  Madden, Lisa J ^a   Zandonatti, Michelle A ^a   Flynn, Claudia T ^a   Taffe, Mike A ^a   Marcondes, M Cecilia G ^a   Schmitz, Jörn E ^b   Reimann, Keith A ^b   Henriksen, Steven J ^a   Fox, Howard S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Fever; HIV; IL 6; MCP 1; SIV

Indexed keywords

ALPHA INTERFERON; CD8 ANTIGEN; CYTOKINE; IMMUNOLOGIC FACTOR; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE DURATION; DISEASE SEVERITY; FEVER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DEPLETION; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SYMPTOMATOLOGY; VIRUS INFECTION; VIRUS LOAD;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; FEVER; INTERFERON-ALPHA; INTERLEUKIN-6; MACACA MULATTA; MALE; MOTOR ACTIVITY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SURVIVAL ANALYSIS; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 1542315465     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490268269     Document Type: Article

References (40)

1. Birx DL, Lewis MG, Vahey M, Tencer K, Zack PM, Brown CR, Jahrling PB, Tosato G, Burke D, Redfield R (1993). Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques. AIDS Res Hum Retroviruses 9: 1123-1129.
2. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB (1994). Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68: 6103-6110.
3. Cartmell T, Poole S, Turnbull AV, Rothwell NJ, Luheshi GN (2000). Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol 526 (Pt 3): 653-661.
4. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G (1998). Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12: 1327-1332.
5. Clark SJ, Shaw GM (1993). The acute retroviral syndrome and the pathogenesis of HIV-1 infection. Semin Immunol 5: 149-155.
6. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 95: 3117-3121.
7. Desrosiers RC (1990). The simian immunodeficiency viruses. Annu Rev Immunol 8: 557-578.
8. Dixon JE, Allan JE, Doherty PC (1987). The acute inflammatory process in murine lymphocytic choriomeningitis is dependent on Lyt-2+ immune T cells. Cell Immunol 107: 8-14.
9. Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay JY, Gabarre J, Gaillard JP, Brochier J, Raphael M (1994). Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 84: 2472-2479.
10. Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ (2000). Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106: 37-45.
11. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL (2000). Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 74: 1648-1657.
12. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762.
13. Gold LH, Fox HS, Henriksen SJ, Buchmeier MJ, Weed MR, Taffe MA, Huitron-Resendiz S, Horn TF, Bloom FE (1998). Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol 27: 104-112.
14. Gruol DL, Nelson TE (1997). Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15: 307-339.
15. Horn TFW, Huitron-Resendiz S, Weed MR, Henriksen SJ, Fox HS (1998). Early physiological abnormalities after simian immunodeficiency virus infection. Proc Natl Acad Sci USA 95: 15072-15077.
16. Johnson RW (2002). The concept of sickness behavior: a brief chronological account of four key discoveries. Vet Immunol Immunopathol 87: 443-450.
17. Kaul M, Garden GA, Lipton SA (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
18. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998). Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus- associated dementia. Ann Neurol 44: 831-835.
19. Khatissian E, Tovey MG, Cumont MC, Monceaux V, Lebon P, Montagnier L, Hurtrel B, Chakrabarti L (1996). The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res Hum Retroviruses 12: 1273-1278.
20. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD (1994). Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650-4655.
21. Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lifton MA, Lord CI, Forman MA, Letvin NL (1999). Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 162: 5127-5133.
22. Kurokawa M, Imakita M, Kumeda CA, Shiraki K (1996). Cascade of fever production in mice infected with influenza virus. J Med Virol 50: 152-158.
23. Lavreys L, Baeten JM, Overbaugh J, Panteleeff DD, Chohan BH, Richardson BA, Mandaliya K, Ndinya-Achola JO, Kreiss JK (2002). Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. Clin Infect Dis 35: 77-81.
24. Marcario JK, Raymond LA, McKiernan BJ, Foresman LL, Joag SV, Raghavan R, Narayan O, Hershberger S, Cheney PD (1999). Simple and choice reaction time performance in SIV-infected rhesus macaques. AIDS Res Hum Retroviruses 15: 571-583.
25. Netea MG, Kullberg BJ, Van der Meer JW (2000). Circulating cytokines as mediators of fever. Clin Infect Dis 31 (Suppl 5): S178-S184.
26. Orandle MS, Williams KC, MacLean AG, Westmoreland SV, Lackner AA (2001). Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J Virol 75: 4448-4452.
27. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, et al (1994). Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370: 463-467.
28. Perrella O, Carrieri PB, Guarnaccia D, Soscia M (1992). Cerebrospinal fluid cytokines in AIDS dementia complex. J Neurol 239: 387-388.
29. Prospero-Garcia O, Gold LH, Fox HS, Polis I, Koob GF, Bloom FE, Henriksen SJ (1996). Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc Natl Acad Sci U S A 93: 14158-14163.
30. Pulliam L, Clarke JA, McGrath MS, Moore D, McGuire D (1996). Monokine products as predictors of AIDS dementia. AIDS 10: 1495-1500.
31. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, Letvin NL (1994). Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 68: 2362-2370.
32. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999a). Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
33. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, Ollert MW, Vogel CW, Racz P, Tenner-Racz K, Scallon BJ, Dalesandro M, Ghrayeb J, Rieber EP, Sasseville VG, Reimann KA (1999b). A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 154: 1923-1932.
34. Sundgren-Andersson AK, Ostlund P, Bartfai T (1998). IL-6 is essential in TNF-alpha-induced fever. Am J Physiol 275: R2028-R2034.
35. Vanhems P, Hirschel B, Phillips AN, Cooper DA, Vizzard J, Brassard J, Perrin L (2000). Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis 182: 334-337.
36. Wallace MR, Nelson JA, McCutchan JA, Wolfson T, Grant I (2001). Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment. Sex Transm Infect 77: 199-201.
37. Watry D, Lane TE, Streb M, Fox HS (1995). Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am J Pathol 146: 914-923.
38. Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL (1993). Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 67: 1707-1711.
39. Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001). Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 184: 1015-1021.
40. Zou W, Lackner AA, Simon M, Durand-Gasselin I, Galanaud P, Desrosiers RC, Emilie D (1997). Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol 71: 1227-1236.